Lucid Diagnostics Inc. Common Stock (LUCD) Stock Price

LUCDStock

$1.01−9.09%52W

Market Cap$192.86M

P/E—

PEG Ratio—

Div yield—

Beta1.16

LUCD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-36.62%

Price vs S&P 500 (4W)6.31%

VGM Score45.64

Book Value / Share (Quarterly)$0.02

P/TBV (Annual)13.45x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)131.36%

Cash Flow / Share (Quarterly)$-0.28

Price vs S&P 500 (YTD)-20.22%

Gross Margin (TTM)-31.38%

Net Profit Margin (TTM)-876.72%

EPS (TTM)$-0.36

10-Day Avg Trading Volume0.88M

EPS Excl Extra (TTM)$-0.36

EPS (Annual)$-0.57

ROI (Annual)-166.05%

Gross Margin (Annual)-41.73%

Net Profit Margin (5Y Avg)-4969.40%

Cash / Share (Quarterly)$0.17

Revenue Growth QoQ (YoY)51.69%

ROA (Last FY)-143.43%

Revenue Growth TTM (YoY)23.03%

EBITD / Share (TTM)$-0.42

Operating Margin (TTM)-980.64%

Cash Flow / Share (Annual)$-0.36

P/B Ratio48.98x

P/B Ratio (Quarterly)50.87x

Net Income / Employee (Annual)$-707,400

EV / Revenue (TTM)37.64x

Net Interest Coverage (TTM)-41.55x

ROA (TTM)-108.20%

EPS Incl Extra (Annual)$-0.57

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.02x

3-Month Avg Trading Volume1.27M

52-Week Price Return-9.09%

Revenue / Employee (TTM)$62,600

Tangible BV / Share (Quarterly)$0.02

P/S Ratio (Annual)41.64x

Asset Turnover (Annual)0.12x

52-Week High$1.63

Operating Margin (5Y Avg)-4903.94%

EPS Excl Extra (Annual)$-0.57

26-Week Price Return-25.37%

Quick Ratio (Annual)1.27x

13-Week Price Return0.00%

Total Debt / Equity (Annual)2.19x

Current Ratio (Quarterly)1.07x

Enterprise Value$193.26M

Asset Turnover (TTM)0.12x

Revenue / Employee (Annual)$57,400

Pretax Margin (Annual)-1232.68%

Cash / Share (Annual)$0.26

3-Month Return Std Dev65.68%

Gross Margin (5Y Avg)-224.39%

Net Income / Employee (TTM)$-548,900

ROE (Last FY)-530.45%

Net Interest Coverage (Annual)-212.25x

EPS Basic Excl Extra (Annual)$-0.57

Receivables Turnover (TTM)13.69x

Total Debt / Equity (Quarterly)6.30x

EPS Incl Extra (TTM)$-0.36

Receivables Turnover (Annual)13.68x

ROI (TTM)-123.80%

P/S Ratio (TTM)38.16x

Pretax Margin (5Y Avg)-4969.40%

Revenue / Share (Annual)$0.05

Tangible BV / Share (Annual)$0.08

Price vs S&P 500 (52W)-27.40%

Year-to-Date Return-8.26%

5-Day Price Return1.06%

EPS Normalized (Annual)$-0.57

ROA (5Y Avg)-141.03%

Net Profit Margin (Annual)-1232.68%

Month-to-Date Return14.73%

Cash Flow / Share (TTM)$-1.34

EBITD / Share (Annual)$-0.49

Operating Margin (Annual)-1077.73%

EPS Basic Excl Extra (TTM)$-0.36

P/TBV (Quarterly)53.69x

P/B Ratio (Annual)13.07x

Inventory Turnover (TTM)14.16x

Pretax Margin (TTM)-876.72%

Book Value / Share (Annual)$0.08

Price vs S&P 500 (13W)-2.79%

Beta1.16x

Revenue / Share (TTM)$0.04

ROE (TTM)-370.21%

52-Week Low$0.86

vGradeF

gGradeA

mGradeC

vgmGradeC

LUCD Earnings Surprise History

Q2 25-0.10est. -0.10

Q3 25-0.10est. -0.09

Q4 25-0.10est. -0.09

Q1 26-0.07est. -0.06

Q2 26-0.06est. -0.06

LUCD Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.18

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
LUCDLucid Diagnostics Inc. Common Stock	F	A	C	$1.01
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Lucid Diagnostics Inc. Common Stock

Lucid Diagnostics is a commercial-stage company developing diagnostic tools for patients with gastroesophageal reflux disease (GERD) at risk of esophageal cancer. Its products, EsoCheck and EsoGuard, enable detection of precancerous changes in the esophagus, addressing an unmet clinical need in cancer prevention. The company targets a significant market opportunity among millions of GERD patients vulnerable to esophageal adenocarcinoma.